Pharma IQ Members

Pharma Industry Report: Single Use & Disposable Technologies for Biomanufacturing 2013

Pharma Industry Series: Disposable Solutions for Biomanufacturing - Special Report 2013

The last 10 years has seen a surge in the use of single-use and disposable systems for the production of biopharmaceuticals, initially in early stage products, but increasingly in commercial products. Exclusively revealing the results of a Pharma IQ  industry-wide survey, almost a quarter of respondents say their number one goal for 2013 is to move single use systems from development into commercial use, and 45% cited cost savings as the biggest factor for doing so.

Interested in learning more about this topic?
Disposable Solutions for Biomanufacturing USA
Disposable Solutions for Biomanufacturing USA
Closing the gaps in single use biomanufacturing; scaling up to commercial levels and overcoming downstream capacity limitations Biomanufacturing and single use are becoming synonymous. Single use found fame in R&D, rose to stardom in clinical manufacturing and is now set on dominating commercial manufacturing scales. However, efficiency savings still need to be maintained and new challenges are arising.

However, understanding the limitations of disposable equipment and the issue of  validation appear to be the greatest challenges for end users who are looking at scaling up for commercial use.

So the question the industry is now asking is where will technology go in the future? And how can new innovations and possibilities with this kind of technology be applied to improve development and manufacturing platforms?

With the upcoming Disposable Solutions for Biomanufacturing Summit in mind, Pharma IQ, shares the current trends and predictions in the Single Use & Disposable Technologies for Biomanufacturing 2013 report. Benchmark against your peers and gain up-to-date insights on the 6 hottest topics in Single Use and Disposable Solutions for Biomanufacturing  in 2013, including :

Ensuring a reliable supply chain to avoid crisis situations with Jerold Martin, Sr. VP, Global Scientific affairs, Biopharmaceuticals at Pall Life Sciences –BPSA .

Combat challenges around standardisation with best practice tips from Janssen Biologics

Drive the quality and safety of your pharmaceutical products through minimising E&Ls: Director of the E&L team at GSK shares practical insights on risk assessments

Overcome transition challenges to scaling up to downstream and commercial use with advice from Pfizer Animal Health and Cobra Biologics

This Special Report is part of our Pharma Industry Series.

 

Thank you, for your interest in Pharma Industry Report: Single Use & Disposable Technologies for Biomanufacturing 2013.

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product.

To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Forgot your password?

Or log in with...

Not a member?

Reasons for Joining
  • Address your challenges through knowledge sharing with peers from our global network of specialists.
  • Benchmark your business initiatives with the who's who in the field.
  • Hear from industry pioneers how to maximize ROI in today's challenging economy.
  • And best of all It's FREE!